Evidence-first workflow
Organize PubMed, ClinVar, scientific context, ACMG draft logic, and review notes into traceable evidence cards.
Blog
Insights for clinical genomics teams.
Articles on variant interpretation, PubMed and ClinVar evidence, ACMG reasoning, clinical AI safety, and regulatory variant intelligence.
Human-review-first
Tynixa creates review-ready drafts only. It does not issue autonomous final diagnosis, treatment, or ACMG classification.
Built for conversion
Each page routes visitors toward Start Trial, Book Demo, Ask Tynixa, or Request Pilot with local analytics tracking.
Clinical safety boundary
Tynixa supports clinical interpretation workflows but requires qualified human review and sign-off. Trial workspaces use demo or synthetic cases only and do not allow production PHI.